Please use this identifier to cite or link to this item:
https://open.uns.ac.rs/handle/123456789/1494
Title: | Disodium cromolyn and anti-podoplanin antibodies strongly inhibit growth of BHK 21/C13-derived fibrosarcoma in a chick embryo chorioallantoic membrane model | Authors: | Maria Anca Cimpean Dušan Lalošević Vesna Lalošević Pavle Banović Marius Raica Alexandru Ovidiu Mederle |
Keywords: | BHK 21/C13 cell line;chick embryo chorioallantoic membrane;experimental therapy;phenotype characterization | Issue Date: | 1-Jul-2018 | Journal: | In Vivo | Abstract: | © 2018 Universidade Federal Rural do Semi-Arido. All Rights Reserved. Aim: To characterize baby hamster kidney fibroblast (BHK 21/C13) cells and test the effects of antibodies against podoplanin and disodium cromolyn on BHK 21/C13 cell line-derived tumors grown on chick embryo chorioallantoic membrane (CAM). Material and Methods: BHK 21/C13 cell-derived fibrosarcomas developed in hamsters were implanted on CAM and treated with anti-podoplanin antibodies and disodium cromolyn. BHK 21/C13 cell immunophenotype was assessed. Results: Fibrosarcoma cells were positive for vimentin, CD117, smooth muscle actin, vascular endothelial growth factor epidermal growth factor receptor, homebox prospero gene 1 and negative for platelet-derived growth factor B, neuron-specific enolase, S100, CD34, Ewing sarcoma and podoplanin. CAM-grown fibrosarcomas were highly sensitive to disodium cromolyn and anti-podoplanin antibodies. Conclusion: Immunophenotyping BHK 21/C13 cells and their response to drugs represent the first step in revealing cell line utility and a reliable tool for experimental cancer research. | URI: | https://open.uns.ac.rs/handle/123456789/1494 | ISSN: | 0258851X | DOI: | 10.21873/invivo.11309 |
Appears in Collections: | POLJF Publikacije/Publications |
Show full item record
SCOPUSTM
Citations
6
checked on May 10, 2024
Page view(s)
32
Last Week
14
14
Last month
0
0
checked on May 10, 2024
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.